Phase II clinical study of SH/TA-508, at ultrasound contrast agent: A dose-finding study of SH/TA-508 in color Doppler flow imaging in the kidney
1995
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI